Chen, Yuh-Min

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Garassino, M. C., Cho, B.-C., Kim, J.-H., Mazières, J., Vansteenkiste, J., Lena, H., Corral Jaime, J., Gray, J. E., Powderly, J., Chouaid, C., et al. (2018) · The Lancet Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 568

Application of Artificial Intelligence in Lung Cancer

Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M. (2022) · Cancers

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 138

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer consortium in Asia

Machiela, M. J., Hsiung, C. A., Shu, X., Seow, W. J., Wang, Z., Matsuo, K., Hong, Y., Seow, A., Wu, C., Hosgood, H. D., et al. (2015) · International Journal of Cancer

Genetic Associations and EpidemiologyTelomeres, Telomerase, and Senescence

Cited by 90

Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan

Chen, Y.-M., Lee, P.-Y., Su, W.-J., & Perng, R.-P. (1992) · Tubercle and Lung Disease

Tuberculosis Research and EpidemiologyDiagnosis and treatment of tuberculosis

Cited by 45

The minimum period of polysomnography required to confirm a diagnosis of severe obstructive sleep apnoea

CHOU, K., CHANG, Y., CHEN, Y., SU, K., PERNG, D., CHANG, S., & SHIAO, G. (2011) · Respirology

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 18

Enhancement of information seeking using an information needs radar model

Shih, C.-W., Chen, M.-Y., Chu, H.-C., & Chen, Y.-M. (2012) · Information Processing & Management

Information Retrieval and Search BehaviorRecommender Systems and Techniques

Cited by 12

Abstract CT504: A phase 1 clinical trial to evaluate safety, tolerability, pharmacokinetics (PK) and efficacy of D-1553, a novel KRASG12C inhibitor, in patients with advanced or metastatic solid tumor harboring KRASG12C mutation

Price, T., Grewal, J., Abed, A., Moore, M., Yeh, Y.-M., Gadgeel, S., Richardson, G., Underhill, C., Ganju, V., Lee, K.-W., et al. (2022) · Cancer Research

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 3